These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18745754)

  • 1. Mapharsen as an Antisyphilitic Arsenical.
    Levin EA
    Cal West Med; 1940 Nov; 53(5):207. PubMed ID: 18745754
    [No Abstract]   [Full Text] [Related]  

  • 2. METHIONINE PROTECTS AGAINST MAPHARSEN LIVER INJURY IN PROTEIN-DEPLETED DOGS.
    Goodell JP; Hanson PC; Hawkins WB
    J Exp Med; 1944 Jun; 79(6):625-32. PubMed ID: 19871391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The neo-arsenic antisyphilitic mapharsen and standard methods of use].
    SASA K
    Nihon Ishikai Zasshi; 1948 Jun; 22(5):166-8. PubMed ID: 18884917
    [No Abstract]   [Full Text] [Related]  

  • 4. Arthur Tatum, Parke-Davis, and the discovery of Mapharsen as an antisyphilitic agent.
    Swann JP
    J Hist Med Allied Sci; 1985 Apr; 40(2):167-87. PubMed ID: 3891839
    [No Abstract]   [Full Text] [Related]  

  • 5. The Antisyphilitic Action and Other Effects of Arsenical Compounds in Relation to Their Constitution.
    Browning CH
    Glasgow Med J; 1921 Nov; 96(5):266-269. PubMed ID: 30435595
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid Treatment of Early Syphilis with Multiple Injections of Mapharsen: Preliminary Report of 275 Cases Treated with Mapharsen Alone and 141 Cases Treated with Mapharsen and Fever.
    Thomas EW; Wexler G
    Am J Public Health Nations Health; 1941 Jun; 31(6):545-56. PubMed ID: 18015442
    [No Abstract]   [Full Text] [Related]  

  • 7. Reiter's syndrome; a report of two cases with response in one to large doses of mapharsen.
    KHOURY EN
    J Urol; 1947 Oct; 58(4):269-71. PubMed ID: 20266241
    [No Abstract]   [Full Text] [Related]  

  • 8. [Jaundice resulting from mapharsen-bismuth and mapharsen-mercury treatment].
    SHAPOSHNIKOV OK
    Vestn Venerol Dermatol; 1948; 29(1):55. PubMed ID: 18887751
    [No Abstract]   [Full Text] [Related]  

  • 9. Arsenical keratosis caused by medication: a case report and literature.
    Zhou S; Zhou J; Liu S; Wang R; Wang Z
    Int J Clin Exp Med; 2015; 8(1):1487-90. PubMed ID: 25785160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of early syphilis with mapharsen].
    SIMONS
    Dermatologica; 1948; 96(1):36. PubMed ID: 18938844
    [No Abstract]   [Full Text] [Related]  

  • 11. The interaction of arsenical drugs with dihydrolipoamide and dihydrolipoamide dehydrogenase from arsenical resistant and sensitive strains of Trypanosoma brucei brucei.
    Fairlamb AH; Smith K; Hunter KJ
    Mol Biochem Parasitol; 1992 Jul; 53(1-2):223-31. PubMed ID: 1501642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological and behavioral factors modify biomarkers of arsenic exposure in a U.S. population.
    Calderon RL; Hudgens EE; Carty C; He B; Le XC; Rogers J; Thomas DJ
    Environ Res; 2013 Oct; 126():134-44. PubMed ID: 23777639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective beta1-integrins expression in arsenical keratosis and arsenic-treated cultured human keratinocytes.
    Lee CH; Chen JS; Sun YL; Liao WT; Zheng YW; Chai CZ; Chen GS; Yu HS
    J Cutan Pathol; 2006 Feb; 33(2):129-38. PubMed ID: 16420308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of recent syphilis in 5 weeks with penicillin, mapharsen, bismuth].
    MARIN A; BOULAIS FL
    Union Med Can; 1948 Jul; 77(7):786-94. PubMed ID: 18874195
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of early syphilis by a 5-week penicillin-mapharsen-bismuth schedule.
    MARIN A; BOULAIS FL
    Can Med Assoc J; 1948 Jul; 59(1):1-7. PubMed ID: 18864227
    [No Abstract]   [Full Text] [Related]  

  • 16. Report of the response of 102 natives to antisyphilitic treatment.
    HUMPHRIES SV
    S Afr Med J; 1947 Aug; 21(16):600-4. PubMed ID: 20265410
    [No Abstract]   [Full Text] [Related]  

  • 17. Alterations of mitogenic responses of mononuclear cells by arsenic in arsenical skin cancers.
    Yu HS; Chang KL; Wang CM; Yu CL
    J Dermatol; 1992 Nov; 19(11):710-4. PubMed ID: 1293158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in properties of adenosine transporters in Trypanosoma evansi and modes of selection of resistance to the melaminophenyl arsenical drug, Mel Cy.
    Suswam EA; Taylor DW; Ross CA; Martin RJ
    Vet Parasitol; 2001 Dec; 102(3):193-208. PubMed ID: 11777599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THE INFLUENCE OF METHYL CHALCONE OF HESPERIDIN ON THE TOXICITY OF MAPHARSEN IN RABBITS.
    Goldstein DH; Stolman A; Goldfarb AE
    Science; 1943 Sep; 98(2541):245-6. PubMed ID: 17752700
    [No Abstract]   [Full Text] [Related]  

  • 20. [The action of mapharsen on serum reactions to the lue].
    MARCHI C
    Rass Med Sarda; 1948; 50 Suppl.(3-4):27-33. PubMed ID: 18105196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.